Ujvira Trastuzumab Emtansine 100mg Injection
Manufacturer: ZYDUS CADILA
Salt: TRASTUZUMAB EMTANSINE 100MG
Category: Anti-Cancer
Price: $275
Availability: In Stock
Ujvira 100mg Injection is a targeted therapy containing the active constituent trastuzumab emtansine. The U.S. Food and Drug Administration (FDA) approved trastuzumab emtansine on February 22, 2013, for treating patients with HER2-positive metastatic breast cancer who have previously received trastuzumab and chemotherapy. This medication is not recommended for adolescents and children under 18. Before taking this medicine, it is vital to inform your doctor if you have any blood clot disorders, liver disorders, or allergies.
Advanced and metastatic breast cancer.
Ujvira Trastuzumab Emtansine 100mg Injection
Product Information
What is Ujvira Trastuzumab Emtansine 100mg Injection?
Ujvira 100mg Injection is a targeted therapy containing the active constituent trastuzumab emtansine. The U.S. Food and Drug Administration (FDA) approved trastuzumab emtansine on February 22, 2013, for treating patients with HER2-positive metastatic breast cancer who have previously received trastuzumab and chemotherapy. This medication is not recommended for adolescents and children under 18. Before taking this medicine, it is vital to inform your doctor if you have any blood clot disorders, liver disorders, or allergies.
Indications for Ujvira Trastuzumab Emtansine 100mg Injection
Advanced and metastatic breast cancer.
Therapeutic Effects of Ujvira Trastuzumab Emtansine 100mg Injection
Trastuzumab binds selectively to the HER2 receptors on breast cancer cells' surface, blocks them from receiving growth signals, and stops the cancer cell's growth. DM1 becomes active once the drug enters the cancer cells and helps stop cancer cell growth.
How to consume Ujvira Trastuzumab Emtansine 100mg Injection
- Ujvira 100mg Injection shall either be administered before or after surgery.
- It will be given as an intravenous infusion for 90 minutes; if well tolerated, it shall be administered within 30 minutes for the next doses.
Side Effects of Ujvira Trastuzumab Emtansine 100mg Injection
Serious:
Heart Problems
Allergic reactions
Kidney problems
Breathing difficulties
Common:
Fever
Visual disturbances
Nose bleeds or runny nose
Hair loss
Dizziness
Nail disorders
Weight loss
Loss of appetite
Bruising
Dry mouth
Liver inflammation
Muscle pain
Asthma/lung disorders
Drug Interactions
Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Ujvira 100mg Injection and cause undesirable side effects.
Storage & Handling
- Store between 2˚C and 8˚C.
- Keep Ujvira 100mg Injection out of sight and reach of children.
Expert Advice
It is suggested to inform your doctor if you have a history of allergic reactions to Ujvira 100mg Injection to avoid life-threatening complications. If you have a history of lung disorder or breathing problems inform your doctor beforehand before the treatment commencement. Avoid planning for pregnancy and breastfeeding for a minimum of 7 months after the last dose. Monitor your heart parameters regularly during the treatment with Ujvira 100mg Injection as it may impact the functioning of heart.
Worldwide Shipping & Delivery
We provide specialized tracked delivery for Ujvira Trastuzumab Emtansine 100mg Injection to multiple countries across the globe. Our logistics network ensures temperature-controlled handling for sensitive oncology medications.
- USA Shipping
- UK Delivery
- UAE & Middle East
- Germany & EU
- Australia
- Canada
Professional Safety Guidelines for Ujvira Trastuzumab Emtansine 100mg Injection
Pregnancy
UnsafeDiscuss with your physician before taking this Ujvira 100mg Injection if you are pregnant or think you might be pregnant. Do not take this medicine during the pregnancy unless advised by the doctor to take as it may cause to the unborn baby.
BreastFeeding
UnsafeAvoid breastfeeding your baby while on the treatment with Ujvira 100mg Injection atleast for at least seven months after the final dose.
Liver
Consult your doctorYou need to tell your physician if you have any liver disorders before starting Ujvira 100mg Injection as it requires dosage adjustment for severe liver impairment.
Lungs
Consult your doctorTalk to your doctor if you have any lung conditions before starting treatment with Ujvira 100mg Injection.
Alcohol
Consult your doctorConsult your doctor to know if it is safe to consume alcohol while you are on treatment with Ujvira 100mg Injection.
Driving
UnsafeUjvira 100mg Injection can cause unusual tiredness and dizziness. Hence, it is advised to avoid driving or handling machinery during the treatment.